Compounds > ketanserin

ketanserin and isoxazoles

ketanserin has been researched along with isoxazoles in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowden, CR; De Coster, R; Heykants, J; Voina, SJ; Woestenborghs, R1
Kido, H; Mori, H; Sakamoto, H; Shiba, K; Sumiyoshi, T; Suzuki, K; Urasaki, K; Yamaguchi, N; Yokogawa, K1
Asanuma, M; Diaz-Corrales, FJ; Miyazaki, I; Miyoshi, K; Murata, M; Ogawa, N1
Candelario-Jalil, E; Fiebich, BL; Koch, FW; Seidel, MF; Ulrich-Merzenich, G; Vetter, H1
Arslan, R; Bektas, N; Ozturk, Y1

Other Studies

5 other study(ies) available for ketanserin and isoxazoles

ArticleYear
Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:2

    Topics: Animals; Antipsychotic Agents; Cells, Cultured; Haloperidol; Isoxazoles; Ketanserin; Male; Piperidines; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Risperidone; Spiro Compounds; Stimulation, Chemical

1992
In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:3

    Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Cerebellum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Isoxazoles; Ketanserin; Ligands; Male; Neostriatum; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone

1994
Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
    Neuroscience research, 2008, Volume: 60, Issue:1

    Topics: alpha-Synuclein; Animals; Antioxidants; Biopterins; Cell-Free System; Cells, Cultured; Cytosol; Dopamine; Isoxazoles; Ketanserin; Lewy Bodies; Melanins; Mice; Neurons; Oxidative Stress; Parkinson Disease; Quinones; Ubiquitin-Protein Ligases; Zonisamide

2008
Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells.
    Rheumatology international, 2008, Volume: 28, Issue:10

    Topics: Aged; Cells, Cultured; Culture Media, Serum-Free; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Drug Interactions; Humans; Indoles; Interleukin-1beta; Isoxazoles; Ketanserin; Leukotriene B4; Macrophages; Middle Aged; Osteoarthritis; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin; Serotonin Agents; Serotonin Antagonists; Synovial Membrane; Tropisetron; Tumor Necrosis Factor-alpha

2008
Zonisamide: Antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.
    Life sciences, 2014, Jan-24, Volume: 95, Issue:1

    Topics: Animals; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Isoxazoles; Ketanserin; Male; Morphine; Ondansetron; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin, 5-HT3; Streptozocin; Zonisamide

2014